# The Pharmacokinetics of Anagrelide in Elderly and Young Patients With Essential Thrombocythaemia (ET)

> **NCT00413634** · PHASE2 · COMPLETED · sponsor: **Shire** · enrollment: 24 (actual)

## Conditions studied

- Essential Thrombocythaemia

## Interventions

- **DRUG:** anagrelide hydrochloride
- **DRUG:** anagrelide hydrochloride

## Key facts

- **NCT ID:** NCT00413634
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11-13
- **Primary completion:** 2008-01-22
- **Final completion:** 2008-01-22
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00413634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00413634, "The Pharmacokinetics of Anagrelide in Elderly and Young Patients With Essential Thrombocythaemia (ET)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00413634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*